Singapūra - angļu - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - octreotide acetate 33.6mg eqv octreotide - injection - 30 mg/vial - octreotide acetate 33.6mg eqv octreotide 30 mg/vial

Singapūra - angļu - HSA (Health Sciences Authority)

astrazeneca singapore pte ltd - zolmitriptan - tablet - 2.5 mg - zolmitriptan 2.5 mg

Singapūra - angļu - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - sumatriptan succinate eqv sumatriptan - tablet, film coated - 50 mg( equivalent to 70mg as succinate) - sumatriptan succinate eqv sumatriptan 50 mg( equivalent to 70mg as succinate)

Singapūra - angļu - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - sumatriptan succinate eqv sumatriptan - injection - 6 mg/0.5 ml - sumatriptan succinate eqv sumatriptan 6 mg/0.5 ml

Singapūra - angļu - HSA (Health Sciences Authority)

dksh singapore pte. ltd. - naproxen sodium - tablet, film coated - 275 mg - naproxen sodium 275 mg

Singapūra - angļu - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - octreotide - injection - 0.1 mg/ml - octreotide 0.1 mg/ml

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

physician therapeutics llc - naproxen (unii: 57y76r9atq) (naproxen - unii:57y76r9atq) - naproxen 500 mg - indications and usage carefully consider the potential benefits and risks of naproxen, naproxen sodium and other treatment options before deciding to use naproxen and naproxen sodium tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings). naproxen as naproxen or naproxen sodium tablets are indicated: - for the relief of the signs and symptoms of rheumatoid arthritis - for the relief of the signs and symptoms of osteoarthritis - for the relief of the signs and symptoms of ankylosing spondylitis - for the relief of the signs and symptoms of juvenile arthritis naproxen as naproxen suspension is recommended for juvenile rheumatoid arthritis in order to obtain the maximum dosage flexibility based on the patient’s weight. naproxen as naproxen and naproxen sodium tablets are also indicated: - for relief of the signs and symptoms of tendonitis - for relief of the signs and symptoms of bursitis - for relief of the signs and symptoms

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - sumatriptan succinate, quantity: 140 mg - tablet - excipient ingredients: croscarmellose sodium; microcrystalline cellulose; lactose; magnesium stearate; colloidal anhydrous silica; crospovidone; titanium dioxide; hypromellose; macrogol 400 - sumatriptan tablets are indicated for the acute relief of migraine attacks with or without aura. there is no information available on the use of sumatriptan tablets in the treatment of basilar or hemiplegic migraine.

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - sumatriptan succinate -

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - sumatriptan succinate, quantity: 70 mg - tablet - excipient ingredients: magnesium stearate; microcrystalline cellulose; croscarmellose sodium; colloidal anhydrous silica; crospovidone; lactose; titanium dioxide; hypromellose; iron oxide red; iron oxide black; macrogol 400 - sumatriptan tablets are indicated for the acute relief of migraine attacks with or without aura. there is no information available on the use of sumatriptan tablets in the treatment of basilar or hemiplegic migraine.